BAQSIMI adverse reactions in pediatric patients
Adverse Reactions (%)
Questionnaire-Solicited Adverse Reactions1,2
Patient-solicited questionnaire identified (treatment-emergent) to be aware of BAQSIMI and glucagon for injection. BAQSIMI included Watery Eyes (47.2%), Nasal Congestion (41.7%), Nasal Itching (27.8%), Runny Nose (25.0%), Sneezing (19.4%), Itchy Eyes (16.7%), Redness of Eyes (13.9%), Itching of Throat (2.8%), and Itching of Ears (2.8%). For glucagon for injection, including Nasal Itching (4.2%), Sneezing (4.2%), Itchy Eyes (12.5%), and Itching of Throat (4.2%), and the following were not reported: Watery Eyes, Nasal Congestion, Runny Nose, Redness of Eyes, and Itching of Ears.†1,2
SELECT IMPORTANT SAFETY INFORMATION
BAQSIMI is contraindicated in patients with pheochromocytoma, insulinoma, and known hypersensitivity to glucagon or to any of the excipients in BAQSIMI. Allergic reactions have been reported with glucagon and include anaphylactic shock with breathing difficulties and hypotension.